These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 25228556)
41. The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL). Rego EM; Kim HT; Ruiz-Argüelles GJ; Uriarte Mdel R; Jacomo RH; Gutiérrez-Aguirre H; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone C; Martinez L; Meillón LA; Gómez-Almaguer D; Kwaan H; Garcés-Eisele J; Gallagher R; Niemeyer CM; Lowenberg B; Ribeiro R; LoCoco F; Sanz MA Hematology; 2012 Apr; 17 Suppl 1():S36-8. PubMed ID: 22507775 [TBL] [Abstract][Full Text] [Related]
42. [All-trans retinoic acid therapy in acute promyelocytic leukemia--current status and prospect]. Kitamura K; Takeshita A; Ono R; Naoe T Rinsho Ketsueki; 1996 Sep; 37(9):760-5. PubMed ID: 8914458 [No Abstract] [Full Text] [Related]
43. [From the molecular model to the impact on prognosis: an overview on acute promyelocytic leukemia]. Jácomo RH; Figueiredo-Pontes LL; Rego EM Rev Assoc Med Bras (1992); 2008; 54(1):82-9. PubMed ID: 18392492 [TBL] [Abstract][Full Text] [Related]
44. Unlocking the potential of retinoic acid in anticancer therapy. Schenk T; Stengel S; Zelent A Br J Cancer; 2014 Nov; 111(11):2039-45. PubMed ID: 25412233 [TBL] [Abstract][Full Text] [Related]
45. Clinico-biological features of 30 patients with acute promyelocytic leukemia and response to combination induction chemotherapy with all-trans retinoic acid and anthracycline. Lim LC; Vellupillai M; Ghafar AA Med Oncol; 2000 Nov; 17(4):301-6. PubMed ID: 11114709 [TBL] [Abstract][Full Text] [Related]
46. Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia from acute myeloid leukemia with multiparameter flow cytometry. Chen Z; Li Y; Tong Y; Gao Q; Mao X; Zhang W; Xia Z; Fu C Int J Hematol; 2016 Mar; 103(3):306-15. PubMed ID: 26759321 [TBL] [Abstract][Full Text] [Related]
47. Acute promyelocytic leukaemia in children. Gregory J; Feusner J Best Pract Res Clin Haematol; 2003 Sep; 16(3):483-94. PubMed ID: 12935964 [TBL] [Abstract][Full Text] [Related]
48. Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy. Abla O; Ribeiro RC; Testi AM; Montesinos P; Creutzig U; Sung L; Di Giuseppe G; Stephens D; Feusner JH; Powell BL; Hasle H; Kaspers GJL; Dalla-Pozza L; Lassaletta A; Tallman MS; Locatelli F; Reinhardt D; Lo-Coco F; Hitzler J; Sanz MA Ann Hematol; 2017 Sep; 96(9):1449-1456. PubMed ID: 28597167 [TBL] [Abstract][Full Text] [Related]
49. Provocative pearls in diagnosing and treating acute promyelocytic leukemia. Stein EM; Tallman MS Oncology (Williston Park); 2012 Jul; 26(7):636-41. PubMed ID: 22888564 [TBL] [Abstract][Full Text] [Related]
51. Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy. Breccia M; Stefania de Propris M; Molica M; Colafigli G; Minotti C; Diverio D; Latagliata R; Guarini A; Lo-Coco F; Foà R Am J Hematol; 2015 Sep; 90(9):E181-2. PubMed ID: 26119985 [No Abstract] [Full Text] [Related]
52. Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Sanz MA; Tallman MS; Lo-Coco F Blood; 2005 Apr; 105(8):3019-25. PubMed ID: 15604216 [TBL] [Abstract][Full Text] [Related]
53. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia. Nasir SS; Giri S; Nunnery S; Martin MG Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483 [TBL] [Abstract][Full Text] [Related]
55. Repeated efficacy of all-trans-retinoic acid in an acute promyelocytic leukemia patient. Watanabe A; Inokuchi K; Mizuki T; Yamaguchi H; Yokose N; Dan K Am J Hematol; 2000 Sep; 65(1):87-8. PubMed ID: 10936873 [No Abstract] [Full Text] [Related]
56. Classification and risk stratification for acute promyelocytic leukemia. Coutre S Clin Lymphoma Myeloma Leuk; 2010 Oct; 10 Suppl 3():S127-9. PubMed ID: 21115430 [TBL] [Abstract][Full Text] [Related]
57. Long-term survival of acute promyelocytic leukaemia patients treated with arsenic and retinoic acid. Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Chen SJ; Huang XJ Br J Haematol; 2016 Sep; 174(5):820-2. PubMed ID: 27545413 [No Abstract] [Full Text] [Related]
58. Mouse models of acute promyelocytic leukemia. Pollock JL; Westervelt P; Walter MJ; Lane AA; Ley TJ Curr Opin Hematol; 2001 Jul; 8(4):206-11. PubMed ID: 11561157 [TBL] [Abstract][Full Text] [Related]
59. What is the best treatment for acute promyelocytic leukemia? Avvisati G; Petti MC; Mandelli F Leuk Lymphoma; 1993; 11 Suppl 2():29-35. PubMed ID: 8124230 [TBL] [Abstract][Full Text] [Related]